Brief ReportsEyelid tumors: accuracy of clinical diagnosis
References (3)
- et al.
Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region
J Am Acad Dermatol
(1991)
Cited by (42)
Statistical evaluation and positive predictive value of key features of periorbital basal cell carcinoma
2023, Canadian Journal of OphthalmologyCitation Excerpt :Assessing the specific features of lesions may improve upon diagnostic accuracy. For instance, a previous investigation based on clinical suspicion alone, Margo12 found 11.6% clinically suspected malignant eyelid tumors to be benign on biopsy. Similarly, Kersten et al8 documented that several lesions that were suspected to be malignant were revealed to be benign on histopathologic assessment.
Ocular Tumors
2019, Abeloff’s Clinical OncologyEye, Orbit, and Adnexal Structures
2013, Abeloff's Clinical Oncology: Fifth EditionA reappraisal of eyelid eccrine and apocrine hidrocystomas: Microanatomic and immunohistochemical studies of 40 lesions
2011, American Journal of OphthalmologyCitation Excerpt :Among the benign lesions (which involved the upper and lower eyelids almost equally), 73 (10.5%) were hidrocystomas (whether eccrine or apocrine was not specified). In about 10% of cases clinical confusion arose, causing misdiagnoses of basal cell carcinomas as hidrocystomas or vice versa, a finding confirmed in a different study.42 In a fourth series43 of 2529 eyelid excisions performed between 1993 and 2002, 91.5% of lesions were histopathologically benign; eccrine and apocrine hidrocystomas were again not distinguished, but together constituted 8% of benign conditions and 7.2% of combined benign and malignant conditions.
Examination Techniques
2007, Clinical Ophthalmic OncologyEyelid Adnexal Tumors
2007, Clinical Ophthalmic Oncology